Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Daybue (trofinetide) Covered by Blue Cross Blue Shield of Texas: Complete Guide to Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting Daybue Covered by BCBS Texas Daybue (trofinetide) requires prior authorization from Blue Cross Blue Shield of Texas and is typically placed in Tier 6 (highest cost-sharing). To get coverage: (1) Your neurologist or geneticist submits a PA request through CoverMyMeds or the BCBS Texas provider portal with
6 min read

How to Get Cystadane (Betaine Anhydrous) Covered by Blue Cross Blue Shield in Georgia: Prior Authorization Forms, Appeals, and Cost-Saving Strategies

Quick Answer: Getting Cystadane Covered by Blue Cross Blue Shield in Georgia Blue Cross Blue Shield Georgia requires prior authorization for Cystadane (betaine anhydrous) due to its specialty status. To get coverage, you need documented genetic confirmation of homocystinuria (CBS, MTHFR, or cobalamin defects), recent homocysteine lab results, and evidence
6 min read

Work With Your Doctor to Get Keytruda (pembrolizumab) Approved by Blue Cross Blue Shield in Washington: Provider Collaboration Guide

Answer Box: Getting Keytruda Approved in Washington Keytruda (pembrolizumab) requires prior authorization from Blue Cross Blue Shield plans in Washington, including Premera and Regence. Your oncologist must submit clinical documentation proving medical necessity, including PD-L1 testing results for certain cancers and evidence of appropriate diagnosis staging. The fastest path: schedule
6 min read

How to Get Brensocatib (BRINSUPRI) Covered by Blue Cross Blue Shield of North Carolina: Complete Prior Authorization Guide 2025

Answer Box: Getting Brensocatib (BRINSUPRI) Covered in North Carolina To get Brensocatib (BRINSUPRI) covered by Blue Cross Blue Shield of North Carolina: Submit a prior authorization request documenting failed macrolide therapy (azithromycin/clarithromycin) and airway clearance treatment, plus at least 2 exacerbations requiring antibiotics in the past year (1 for
7 min read